Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivoSuresh Radhakrishnan, Rosalyn Cabrera, Erin L Schenk, et al.
Investigational New Drugs|January 19, 2010
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumorsJoleen Hubbard, Charles Erlichman, David O Toft, et al.
Cell Stress & Chaperones|October 23, 2004
Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70Amerigo Carrello, Rudi K Allan, Sarah L Morgan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancerGrzegorz S Nowakowski, Andrea K McCollum, Matthew M Ames, et al.
Molecular Cell|May 27, 2005
HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptorJeffrey J Kovacs, Patrick J M Murphy, Stéphanie Gaillard, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2015
Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patientsSara J Felts, Virginia P Van Keulen, Adam D Scheid, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast CancerSara J Felts, Virginia P Van Keulen, Michael J Hansen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2018
Gene Expression Signatures Characterized by Longitudinal Stability and Interindividual Variability Delineate Baseline Phenotypic Groups with Distinct Responses to Immune StimulationAdam D Scheid, Virginia P Van Keulen, Sara J Felts, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigensJames William Jenkins, Alvaro Peña, Sarah A Castro, et al.
Pageof 4